Image

Exercise Program for Arteriovenous Fistula Maturation

Exercise Program for Arteriovenous Fistula Maturation

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Arteriovenous fistula (AVF) is the recommended vascular access for chronic hemodialysis, as it is associated with less mortality and better patency than arteriovenous graft (AVG) or central venous catheter (CVC).

Unfortunately, AVF suffers from a high failure rate, due, in part, to poor venous diameter.

The aim of this study is to investigate whether a perioperative handgrip training can improve the diameter of AVF in patients with chronic kidney disease (CKD) (stage IV-V).

Eligibility

Inclusion Criteria:

  • Patients older than 18 years
  • with chronic kidney disease (Estimated Glomerular Filtration Rate (eGFR) <30 milliLiter/minute (mL/min))
  • with follow-up at the University Hospital of Lyon Sud
  • who choose hemodialysis as renal replacement therapy

Exclusion Criteria:

  • contraindication for arteriovenous fistula (AVF) surgery
  • refusing AVF creation
  • prior vascular access
  • antecedent of IV substance abuse
  • active cancer
  • inability to perform handgrip exercise
  • physical or mental disability limiting follow-up possibility
  • inclusion in an other interventional study
  • no social welfare

Study details
    Arteriovenous Fistula

NCT04034433

Hospices Civils de Lyon

28 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.